These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30891143)

  • 1. Expanded Structure-Activity Studies of Lipoxazolidinone Antibiotics.
    Robinson KR; Mills JJ; Pierce JG
    ACS Med Chem Lett; 2019 Mar; 10(3):374-377. PubMed ID: 30891143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.
    Valdes-Pena MA; Massaro NP; Lin YC; Pierce JG
    Acc Chem Res; 2021 Apr; 54(8):1866-1877. PubMed ID: 33733746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920.
    Sunga MJ; Teisan S; Tsueng G; Macherla VR; Lam KS
    J Ind Microbiol Biotechnol; 2008 Jul; 35(7):761-5. PubMed ID: 18389298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Evaluation of the Antimicrobial Natural Product Lipoxazolidinone A.
    Mills JJ; Robinson KR; Zehnder TE; Pierce JG
    Angew Chem Int Ed Engl; 2018 Jul; 57(28):8682-8686. PubMed ID: 29845720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxazolidinones A, B, and C: antibacterial 4-oxazolidinones from a marine actinomycete isolated from a Guam marine sediment.
    Macherla VR; Liu J; Sunga M; White DJ; Grodberg J; Teisan S; Lam KS; Potts BC
    J Nat Prod; 2007 Sep; 70(9):1454-7. PubMed ID: 17845000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Qualitative Structure Activity Relationship Evaluations of Quinoline-Based Bisarylimidazoles as Antibacterial Motifs.
    Al-Qawasmeh RA; Huthail BB; Sinnokrot MO; Semreen MH; Odeh RA; Abu-Zarga MH; Tarazi H; Yousef IA; Al-Tel TH
    Med Chem; 2016; 12(6):563-73. PubMed ID: 27188185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
    Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
    Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
    mSystems; 2020 May; 5(3):. PubMed ID: 32457238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of
    Donner J; Reck M; Bunk B; Jarek M; App CB; Meier-Kolthoff JP; Overmann J; Müller R; Kirschning A; Wagner-Döbler I
    mSphere; 2017; 2(5):. PubMed ID: 28959742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid synthesis and antimicrobial activity of novel 4-oxazolidinone heterocycles.
    Shymanska NV; An IH; Guevara-Zuluaga S; Pierce JG
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4887-4889. PubMed ID: 26099542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of novel oxazolidinone analogs and 13 conventional antimicrobial agents against clinical isolates of Staphylococcus aureus in Beijing, China.
    Lei H; Jiang Y; Wang D; Gong P; Li Y; Dong Y; Dong M
    Jpn J Infect Dis; 2014; 67(5):402-4. PubMed ID: 25241696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
    Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.
    Spaulding A; Takrouri K; Mahalingam P; Cleary DC; Cooper HD; Zucchi P; Tear W; Koleva B; Beuning PJ; Hirsch EB; Aggen JB
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5310-5321. PubMed ID: 29102393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
    Siddiqui AM; Sattigeri JA; Javed K; Shafi S; Shamim M; Singhal S; Malik ZM
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1198-1206. PubMed ID: 29525219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections.
    Zha GF; Wang SM; Rakesh KP; Bukhari SNA; Manukumar HM; Vivek HK; Mallesha N; Qin HL
    Eur J Med Chem; 2019 Jan; 162():364-377. PubMed ID: 30453245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).
    Mohammad H; Reddy PV; Monteleone D; Mayhoub AS; Cushman M; Seleem MN
    Eur J Med Chem; 2015 Apr; 94():306-16. PubMed ID: 25771109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes.
    Omosa LK; Midiwo JO; Mbaveng AT; Tankeo SB; Seukep JA; Voukeng IK; Dzotam JK; Isemeki J; Derese S; Omolle RA; Efferth T; Kuete V
    Springerplus; 2016; 5(1):901. PubMed ID: 27386347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.